Article

Subretinal device improves visual function in RP patients

Author(s):

Fort Lauderdale, FL-Visual function improvement is still apparent and better than ex-pected more than 3 years following the first implantation of a subretinal Artificial Silicon Retina (ASR, Optobionics Corp.) micro-chip in patients experiencing vision loss from retinitis pigmentosa (RP). This degree of improvement could be due at least in part to a neurotrophic effect, said Alan Y. Chow, MD, co-developer of the ASR.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.